Reserpine-induced fibromyalgia model in female rats is a long-lasting painful condition masked by antinociceptive endogenous opioids
Frontiers in Pharmacology · 18.03.2026 · 17
DOI: 10.3389/fphar.2026.1733691 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Pharmacology, online erschienen am 18.03.2026. Verfasst von Cristina Juárez-Núñez und 6 weiteren Autor:innen. Beteiligte Einrichtung: Laboratorio de Fisiología Celular, Instituto Nacional de Psiquiatría Ramón de la Fuente Muñiz, Ciudad de México, Mexico. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Fibromyalgia (FM) is a chronic painful condition that primarily affects women. The allodynia and hyperalgesia induced by reserpine is a FM model commonly used to study the disease; however, it produces one painful episode, in contrast to FM, which is a chronic painful condition. Reserpine induces hypersensitivity for 10 days, which is resolved by day-21. In this study, we sought to determine whether the resolution of pain was due to the release of endogenous antinociceptive opioids and the activation of spinal opioid receptors.
Methods
Female Wistar rats were used in this study. To induce a fibromyalgia-like model, reserpine was subcutaneously administered. Twenty-one days after reserpine administration, subcutaneous or intrathecal opioid blockers were administered to evaluate latent sensitization. Additionally, serum β-endorphin concentration was determined by ELISA.
Results
Reserpine produced transitory hyperalgesia and allodynia, which was resolved by day 21. Systemic administration of naloxone on days 21, 33, and 45 reinstated hypersensitivity. Likewise, intrathecal administration of naltrexone or specific antagonists of μ and δ opioid receptors (CTOP and naltrindole) reinstated hypersensitivity. These results suggest that an increased concentration of opioid agonists in reserpinized animals leads to antinociceptive effects. Accordingly, reserpine injection enhanced serum β-endorphin concentration in female rats.
Conclusion
Our data suggest that reserpine-induced nociceptive hypersensitivity is a long-lasting condition masked by the compensatory release of β-endorphin and the activation of spinal µ and, to a lesser extent, δ opioid receptors.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Laboratorio de Fisiología Celular, Instituto Nacional de Psiquiatría Ramón de la Fuente Muñiz, Ciudad de México, Mexico.
- Investigador por México, Secretaría de Ciencias, Humanidades, Tecnología e Innovación, Ciudad de México, Mexico.
- Neurobiology of Pain Laboratory, Departamento de Farmacobiología, Cinvestav, South Campus, Mexico City, Mexico.
- Laboratorio de Neurofisiología Integrativa, Instituto Nacional de Psiquiatría Ramón de la Fuente Muñiz, Ciudad de México, Mexico.
Zitieren
APA
Juárez-Núñez, C., Segura-Chama, P., Pizaña-Encarnación, J. M., Pellicer, F., Granados-Soto, V., Mercado, F., & Almanza, A. (2026). Reserpine-induced fibromyalgia model in female rats is a long-lasting painful condition masked by antinociceptive endogenous opioids. Frontiers in Pharmacology, 17. https://doi.org/10.3389/fphar.2026.1733691
Vancouver
Juárez-Núñez C, Segura-Chama P, Pizaña-Encarnación JM, Pellicer F, Granados-Soto V, Mercado F, et al. Reserpine-induced fibromyalgia model in female rats is a long-lasting painful condition masked by antinociceptive endogenous opioids. Frontiers in Pharmacology. 2026;17. doi:10.3389/fphar.2026.1733691
BibTeX
@article{JurezNez2026,
author = {Juárez-Núñez, Cristina and Segura-Chama, Pedro and Pizaña-Encarnación, Juan Miguel and Pellicer, Francisco and Granados-Soto, Vinicio and Mercado, Francisco and Almanza, Angélica},
title = {Reserpine-induced fibromyalgia model in female rats is a long-lasting painful condition masked by antinociceptive endogenous opioids},
journal = {Frontiers in Pharmacology},
year = {2026},
volume = {17},
doi = {10.3389/fphar.2026.1733691}
}
EUVIMED